Efficacy and safety of vildagliptin, Saxagliptin or Sitagliptin as add-on therapy in Chinese patients with type 2 diabetes inadequately controlled with dual combination of traditional oral…

Overview of attention for article published in Diabetology & Metabolic Syndrome, May 2014

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (54th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 26 Dimensions

Readers on

mendeley: 66 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

LOW-DOSE TRIPLE COMBINATION FORMULATION

Application EP-3946343-A4

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.